Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary Characterization of Rare MPL Y591 and R592 Variants in Myeloid Disorders: From Clinical Correlation and Literature-Based Evidence to In Silico Predictors and Structural Bioinformatics.

Experimental hematology·2026
Same author

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026
Same author

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same author

Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission.

Cancers·2026
Same author

CD56<sup>+</sup>/CD38<sup>+</sup> Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Timing and Pattern of Extraosseous Dissemination Are Key Determinants of Survival in Multiple Myeloma.

American journal of hematology·2026

Related Experiment Video

Updated: Oct 2, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

Software Workflows and Infrastructures for Precision Oncology.

Waleed Osman1, Alessandro Laganà2

  • 1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Advances in Experimental Medicine and Biology
|March 1, 2022
PubMed
Summary
This summary is machine-generated.

Precision oncology uses patient genetic data for targeted cancer treatments. This guide details computational tools and infrastructure for reproducible precision oncology pipelines, addressing big data challenges.

Keywords:
BioinformaticsCWLGenomics data processingPipelinePrecision oncologySoftware infrastructureWorkflowWorkflow management system

More Related Videos

Workflow for High-content, Individual Cell Quantification of Fluorescent Markers from Universal Microscope Data, Supported by Open Source Software
09:57

Workflow for High-content, Individual Cell Quantification of Fluorescent Markers from Universal Microscope Data, Supported by Open Source Software

Published on: December 16, 2014

13.1K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.1K

Related Experiment Videos

Last Updated: Oct 2, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Workflow for High-content, Individual Cell Quantification of Fluorescent Markers from Universal Microscope Data, Supported by Open Source Software
09:57

Workflow for High-content, Individual Cell Quantification of Fluorescent Markers from Universal Microscope Data, Supported by Open Source Software

Published on: December 16, 2014

13.1K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.1K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Precision oncology leverages high-throughput sequencing for patient profiling.
  • Analyzing large genomic datasets requires robust computational tools.
  • Reproducibility and data handling are key challenges in precision oncology workflows.

Purpose of the Study:

  • To describe tools for designing and implementing precision oncology pipelines.
  • To highlight technical considerations for effective tool utilization.
  • To guide the development of precision oncology software workflows and infrastructure.

Main Methods:

  • Review of existing computational tools for genomic data analysis.
  • Discussion of infrastructure requirements for large-scale data processing.
  • Emphasis on software workflow design for reproducibility.

Main Results:

  • Identification of various tools for precision oncology pipeline development.
  • Outlined technical considerations for efficient data analysis.
  • Provided a framework for building reproducible bioinformatics workflows.

Conclusions:

  • Effective implementation of precision oncology requires careful selection of computational tools.
  • Robust infrastructure and reproducible software workflows are essential for success.
  • Addressing data handling challenges ensures reliable genomic profiling for cancer treatment.